Fig. 8From: Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitorsThe 3D and 2D interaction of the Simeprevir (second generation approved direct-acting antiviral agent) (Molecule 15, see Table 6) with the binding pocket of 3D structures of HCV NS3/4a protease/helicase (PDB ID: 4A92)Back to article page